Gainers
- Akebia Therapeutics AKBA stock moved upwards by 25.7% to $0.93 during Thursday's after-market session. This security traded at a volume of 1.6 million shares come close, making up 75.7% of its average volume over the last 100 days. The company's market cap stands at $171.0 million.
- Lipocine LPCN stock increased by 17.29% to $0.53. The market value of their outstanding shares is at $46.8 million.
- Anixa Biosciences ANIX shares rose 16.58% to $4.5. The company's market cap stands at $139.1 million.
- ABVC BioPharma ABVC shares rose 9.56% to $0.8. Trading volume for this security closed at 296.4K, accounting for 36.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $26.1 million.
- Insulet PODD stock moved upwards by 7.19% to $319.0. The company's market cap stands at $22.1 billion. The company's, Q4 earnings came out today.
- Medigus MDGS shares moved upwards by 7.14% to $4.95. The market value of their outstanding shares is at $8.1 million.
Losers
- SELLAS Life Sciences Gr SLS shares decreased by 33.6% to $2.45 during Thursday's after-market session. At the close, SELLAS Life Sciences Gr's trading volume reached 126.2K shares. This is 75.9% of its average volume over the last 100 days. The company's market cap stands at $50.4 million.
- Tactile Systems Tech TCMD stock decreased by 13.76% to $12.35. The company's market cap stands at $250.0 million. As per the press release, Q4 earnings came out 2 days ago.
- Benitec Biopharma BNTC stock declined by 6.91% to $0.24. The company's market cap stands at $6.7 million.
- Ontrak OTRK stock decreased by 5.74% to $0.62. The company's market cap stands at $16.9 million.
- Nexalin Technology NXL shares decreased by 5.46% to $0.84. The company's market cap stands at $6.0 million.
- Vir Biotechnology VIR shares declined by 4.97% to $24.5. Trading volume for this security closed at 93.7K, accounting for 11.2% of its average full-day volume over the last 100 days. The company's market cap stands at $3.2 billion. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ABVCABVC BioPharma Inc
$2.94-1.34%
Edge Rankings
Momentum
99.27
Growth
N/A
Quality
N/A
Value
6.56
Price Trend
Short
Medium
Long
AKBAAkebia Therapeutics Inc
$3.715.70%
ANIXAnixa Biosciences Inc
$3.203.23%
BNTCBenitec Biopharma Inc
$11.332.53%
LPCNLipocine Inc
$3.393.67%
NXLNexalin Technology Inc
$1.04-2.36%
OTRKOntrak Inc
$0.4783-2.34%
PODDInsulet Corp
$297.201.96%
SLSSELLAS Life Sciences Group Inc
$1.742.66%
TCMDTactile Systems Technology Inc
$10.320.15%
VIRVir Biotechnology Inc
$5.412.95%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.